Target
Cathepsin E
Ligand
BDBM202627
Substrate
n/a
Meas. Tech.
Fluorescent Substrate Kinetic Assay
pH
5.5±n/a
Temperature
298.15±n/a K
IC50
5000±n/a nM
Comments
extracted
Citation
 Andreini, MGabellieri, EGuba, WHilpert, HMayweg, AVNarquizian, RPower, ETravagli, MWoltering, TWostl, WMauser, H 1,4 oxazines as BACE1 and/or BACE2 inhibitors US Patent  US9242943 Publication Date 1/26/2016 
Target
Name:
Cathepsin E
Synonyms:
3.4.23.34 | CATE_HUMAN | CTSE | Cathepsin E form I | Cathepsin E form II
Type:
Enzyme
Mol. Mass.:
43298.99
Organism:
Homo sapiens (Human)
Description:
P14091
Residue:
396
Sequence:
MKTLLLLLLVLLELGEAQGSLHRVPLRRHPSLKKKLRARSQLSEFWKSHNLDMIQFTESCSMDQSAKEPLINYLDMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSRFQPSQSSTYSQPGQSFSIQYGTGSLSGIIGADQVSVEGLTVVGQQFGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYMSSNPEGGAGSELIFGGYDHSHFSGSLNWVPVTKQAYWQIALDNIQVGGTVMFCSEGCQAIVDTGTSLITGPSDKIKQLQNAIGAAPVDGEYAVECANLNVMPDVTFTINGVPYTLSPTAYTLLDFVDGMQFCSSGFQGLDIHPPAGPLWILGDVFIRQFYSVFDRGNNRVGLAPAVP
  
Inhibitor
Name:
BDBM202627
Synonyms:
US9242943, 36
Type:
Small organic molecule
Emp. Form.:
C20H18ClFN4O
Mol. Mass.:
384.835
SMILES:
CC1(COCC(N)=N1)c1cccc(Nc2cc(F)cc3cc(Cl)cnc23)c1 |c:6|
Structure:
Search PDB for entries with ligand similarity: